Key result
Disrupting the ACTA2-directed actin network rescues lethal autoimmunity in mice and reduces SLE inflammatory signatures.
Why the study?
Does disruption of ACTA2-directed actin filaments prevent STING-dependent inflammatory responses and autoimmunity in preclinical models?
Does disruption of ACTA2-directed actin filaments prevent STING-dependent inflammatory responses and autoimmunity in preclinical models?
ACTA2-directed actin filaments are essential for STING trafficking and activation, presenting a potential therapeutic target for STING-driven autoimmune diseases.
ACTA2 disruption may suppress STING-mediated autoimmunity; hypothesis-generating in preclinical models and requires clinical validation.
The cyclic GMP-AMP synthase–stimulator of interferon genes (STING) pathway is essential for antiviral immunity, and its dysregulation causes inflammatory disease. The mechanism underlying STING activation, including its essential endoplasmic reticulum-to-Golgi translocation, has remained elusive. Here, we identify a dedicated actin-based transport system licensed by the smooth muscle actin isoform ACTA2 via in vitro reconstitution. Superresolution live imaging reveals STING becomes punctate and activated while moving along ACTA2 filaments. This ACTA2-directed network is required for antiviral interferon responses against HSV-1. Strikingly, it also drives pathological interferon production and lethal autoimmunity in Trex1 −/− mice, where its genetic or pharmacological disruption rescues disease. Furthermore, ACTA2 expression correlates with proinflammatory cytokine levels in peripheral blood mononuclear cells from systemic lupus erythematosus patients, and its downregulation ameliorates this inflammatory signature. Our work defines a specific cytoskeletal network that governs STING-dependent inflammatory responses to both foreign and self-DNA, thereby establishing stimulus-directed organelle trafficking as a central control point in innate immune signaling.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied Systemic lupus erythematosus (SLE) / Autoimmunity. Genetic or pharmacological disruption of ACTA2 was evaluated on STING trafficking, activation, and interferon production. Genetic or pharmacological disruption of the ACTA2-directed actin transport network rescued lethal autoimmunity in Trex1 -/- mice and ameliorated inflammatory signatures in SLE patient cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: